Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03549312 |
|
Recruitment Status : Unknown
Verified December 2019 by Alexander Wong, MD, Saskatchewan Health Authority - Regina Area.
Recruitment status was: Recruiting
First Posted : June 8, 2018
Last Update Posted : December 24, 2019
|
Sponsor:
Saskatchewan Health Authority - Regina Area
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Alexander Wong, MD, Saskatchewan Health Authority - Regina Area
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | July 21, 2020 |
| Estimated Study Completion Date : | June 22, 2021 |